Ratings by Barclays (Glen Santangelo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/18/2026 | Indivior | INDV | New Coverage | Overweight (N/A) |
38.01 (41.26) |
8.55% | Details | |
| 6/17/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/1/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/29/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2026 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/18/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2026 | Phreesia Inc. | PHR | Downgrade | Equalweight (Overweight) |
9.19 (10.29) |
11.97% | Details | |
| 5/14/2026 | Doximity Inc | DOCS | Downgrade | Equalweight (Overweight) |
23.39 (20.59) |
-11.97% | Details | |
| 5/6/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2026 | Claritev | CTEV | New Coverage | Overweight (N/A) |
21.91 (33.82) |
54.36% | Details | |
| 4/8/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/27/2026 | Phathom Pharmaceuticals | PHAT | Upgrade | Overweight (Equalweight) |
10.47 (10.87) |
3.82% | Details | |
| 3/26/2026 | Teladoc | TDOC | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/23/2026 | Alvotech SA | ALVO | Maintain | Underweight (N/A) |
|
Details | ||
| 3/23/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2026 | ANI Pharmaceuticals | ANIP | Maintain | Overweight (N/A) |
|
Details | ||
| 3/17/2026 | Align Technology | ALGN | Upgrade | Overweight (Equalweight) |
164.23 (173.43) |
5.6% | Details | |
| 3/11/2026 | Hims and Hers | HIMS | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/9/2026 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/6/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2026 | Align Technology | ALGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/25/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2026 | Bausch Health Companies | BHC | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/24/2026 | Organon & Co. | OGN | Maintain | Underweight (N/A) |
|
Details | ||
| 2/24/2026 | Cardinal Health | CAH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2026 | TalkSpace | TALK | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/18/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2026 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Overweight (N/A) |
41.25 (39.61) |
-3.98% | Details | |
| 1/9/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/16/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/9/2025 | Organon & Co. | OGN | New Coverage | Underweight (N/A) |
7.14 (13.55) |
89.78% | Details | |
| 12/9/2025 | Collegium Pharmaceutical | COLL | New Coverage | Overweight (N/A) |
47.91 (35.98) |
-24.9% | Details | |
| 12/9/2025 | Amphastar Pharmaceuticals | AMPH | New Coverage | Equalweight (N/A) |
26.77 (20.71) |
-22.64% | Details | |
| 12/9/2025 | Phathom Pharmaceuticals | PHAT | New Coverage | Equalweight (N/A) |
14.58 (10.87) |
-25.45% | Details | |
| 12/9/2025 | Teva Pharma | TEVA | New Coverage | Overweight (N/A) |
28.46 (33.31) |
17.04% | Details | |
| 12/9/2025 | Amneal Pharmaceuticals | AMRX | New Coverage | Overweight (N/A) |
12.18 (17.29) |
41.95% | Details | |
| 12/9/2025 | Tarsus Pharmaceuticals | TARS | New Coverage | Overweight (N/A) |
81.77 (61.26) |
-25.08% | Details | |
| 12/9/2025 | Alvotech SA | ALVO | New Coverage | Underweight (N/A) |
5.47 (3.72) |
-31.99% | Details | |
| 12/9/2025 | Viatris | VTRS | New Coverage | Overweight (N/A) |
10.93 (16.23) |
48.49% | Details | |
| 12/9/2025 | Pacira Pharmaceuticals | PCRX | New Coverage | Equalweight (N/A) |
23.99 (25.09) |
4.59% | Details | |
| 12/9/2025 | Bausch Health Companies | BHC | New Coverage | Equalweight (N/A) |
6.93 (4.85) |
-30.01% | Details | |
| 12/9/2025 | Elanco Animal Health | ELAN | New Coverage | Overweight (N/A) |
21.90 (24.74) |
12.97% | Details | |
| 12/9/2025 | Teladoc | TDOC | New Coverage | Equalweight (N/A) |
7.59 (8.69) |
14.49% | Details | |
| 12/9/2025 | Progyny | PGNY | New Coverage | Overweight (N/A) |
24.02 (28.86) |
20.15% | Details | |
| 12/9/2025 | Phreesia Inc. | PHR | New Coverage | Overweight (N/A) |
20.29 (10.29) |
-49.29% | Details | |
| 12/9/2025 | TalkSpace | TALk | New Coverage | Equalweight (N/A) |
3.08 (5.20) |
68.83% | Details | |
| 12/9/2025 | Zoetis Inc. | ZTS | New Coverage | Equalweight (N/A) |
118.65 (73.25) |
-38.26% | Details | |
| 12/9/2025 | Henry Schein | HSIC | New Coverage | Overweight (N/A) |
73.62 (84.29) |
14.49% | Details | |
| 12/9/2025 | Envista Holdings Corp. | NVST | New Coverage | Overweight (N/A) |
20.23 (27.02) |
33.56% | Details | |
| 12/9/2025 | Cencora Inc | COR | New Coverage | Overweight (N/A) |
339.66 (281.65) |
-17.08% | Details | |
| 12/9/2025 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
714.10 (535.93) |
-24.95% | Details | |
| 12/9/2025 | Cardinal Health | CAH | New Coverage | Overweight (N/A) |
198.83 (236.22) |
18.81% | Details | |
| 12/9/2025 | Lifestance Health Group | LFST | New Coverage | Overweight (N/A) |
6.48 (10.34) |
59.57% | Details | |
| 12/9/2025 | GoodRx Holdings Inc. | GDRX | New Coverage | Underweight (N/A) |
2.71 (2.85) |
5.17% | Details | |
| 12/9/2025 | McKesson | MCK | New Coverage | Overweight (N/A) |
808.62 (747.53) |
-7.55% | Details | |
| 12/9/2025 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
94.51 (87.81) |
-7.09% | Details | |
| 12/9/2025 | Doximity Inc | DOCS | New Coverage | Overweight (N/A) |
45.93 (20.59) |
-55.17% | Details | |
| 12/9/2025 | Align Technology | ALGN | New Coverage | Equalweight (N/A) |
157.21 (164.23) |
4.47% | Details |
